Cystoid Macular Edema Occurring After Intracameral Bimatoprost Implantation
Published 2024 - 42nd Congress of the ESCRS
Reference: PO023 | Type: Case Report | DOI: 10.82333/dn3k-eq28
Authors: Emmanuel Bettach* 1 , Rony Wiener 1 , Kobi Brosh 1 , David Zadok 1 , Mordechai Goldberg 1
1shaare zedek medical center,Jerusalem,Israel
Purpose
This case report aims to report the development of cystoid macular edema (CME) unilaterally following the administration of bimatoprost implant (Durysta) injections in both eyes for the treatment of primary open-angle glaucoma (POAG).
Setting
Shaare Zedek medical center, case report
Report of case
A 84-year-old female patient, with an ocular background of past left pseudophakic CME and previously diagnosed with POAG, underwent bimatoprost implant (Durysta) injections in both eyes, spaced one month apart. Subsequently, the patient experienced a gradual decline in visual acuity in her left eye attributed to the development of CME. The condition resolved following a treatment regimen involving topical dexamethasone and nepafenac.
Conclusion/Take home message
The use of bimatoprost implant may lead to the occurrence of CME. Ophthalmologists must vigilantly monitor patients post-implantation, especially if they exhibit visual symptoms or have risk factors for a CME